Catalyst Wire Dossier Catalyst Wire Dossier

Exosome therapy (ocular involvement in Sjögren's syndrome)

exosome-based therapy · Guangdong ProCapZoom Biosciences Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Exosome therapy (ocular involvement in Sjögren's syndrome), covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Exosomes in Patients With Ocular Involvement of Sjögren's Syndrome [EARLY_Phase 1]

See pricing